Circulating Tumor DNA in Patients Summoned for Colonoscopy; - a Liquid Biopsy for Detection, Characterization, Individualized Treatment and Follow-up of Colorectal Cancer

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2028

Conditions
Colorectal CancerColorectal Adenoma
Interventions
DIAGNOSTIC_TEST

liquid biopsy

based on a panel of circulating tumor DNA markers

Trial Locations (1)

N-7600

RECRUITING

Nord-Trøndelag Hospital Trust, Levanger

All Listed Sponsors
collaborator

Norwegian University of Science and Technology

OTHER

lead

Helse Nord-Trøndelag HF

OTHER